| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.90B | 17.45B | 14.87B | 14.04B | 10.48B | 6.27B |
| Gross Profit | 3.74B | 3.36B | 2.37B | 2.86B | 1.63B | 857.36M |
| EBITDA | 2.37B | 2.34B | 1.87B | 1.30B | 595.97M | 259.52M |
| Net Income | 1.54B | 1.53B | 1.23B | 814.10M | 306.33M | 53.22M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 11.56B | 9.94B | 10.10B | 8.77B | 6.71B |
| Cash, Cash Equivalents and Short-Term Investments | 236.63M | 236.63M | 51.12M | 242.14M | 294.17M | 239.53M |
| Total Debt | 0.00 | 430.02M | 325.46M | 424.32M | 460.58M | 714.11M |
| Total Liabilities | -7.29B | 4.26B | 4.06B | 5.44B | 4.92B | 3.17B |
| Stockholders Equity | 7.29B | 7.29B | 5.89B | 4.66B | 3.85B | 3.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 227.34M | -47.84M | 27.04M | 193.31M | -169.67M |
| Operating Cash Flow | 0.00 | 530.63M | 161.02M | 272.39M | 382.42M | -18.95M |
| Investing Cash Flow | 0.00 | -302.44M | 19.22M | -241.56M | -181.31M | -139.16M |
| Financing Cash Flow | 0.00 | 2.66M | -83.29M | -210.00M | -152.65M | 172.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹63.59B | 18.34 | ― | 0.15% | 39.60% | 36.23% | |
73 Outperform | ₹35.59B | 17.61 | ― | 0.56% | 5.82% | -69.82% | |
73 Outperform | ₹61.71B | 35.91 | ― | 0.22% | 14.35% | 21.34% | |
70 Outperform | ₹35.97B | 26.33 | ― | 0.08% | 15.47% | -1.72% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ₹32.14B | 256.89 | ― | 0.06% | 8.07% | -52.26% | |
57 Neutral | ₹32.35B | 15.86 | ― | ― | -12.76% | -17.59% |
Kingfa Science & Technology (India) Limited has announced a reconstitution of its Board of Directors’ committees, effective from late August 2025. This restructuring includes changes in the Audit, Nomination and Remuneration, and Corporate Social Responsibility Committees, following the completion of Mr. Dilip Dinkar Kulkarni’s term and the resignation of Mr. Wu Xiaohui. These changes are aimed at strengthening the company’s governance and aligning with strategic objectives, potentially impacting its operational efficiency and stakeholder confidence.